http://www.yso.fi/onto/yso/p20931 Non-Hodgkin lymphomas
Non-Hodgkin lymphomas
Resistance mechanisms of non-Hodgkin lymphomas against Rituximab treatment
Serum CD44 levels preceding the diagnosis of non-Hodgkin's lymphoma
Autologous stem cell transplantation in patients with non-Hodgkin's lymphoma : progenitor cell mobilisation, toxicity of high-dose therapy, and progressive disease after transplantation
Osteonecrosis in children, adolescents and young adults treated for cancer
Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma
Mantle cell lymphoma : clinicopathological features and prognostic factors
Clinical significance of circulating CD44 in non-Hodgkin's lymphoma
Changes in DNA sequence copy number in diffuse large B-cell and mantle cell lymphoma
Prognostic molecular factors and algorithms in diffuse large B-cell lymphoma
A high pretreatment serum basic fibroblast growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin's lymphoma
BCL2 overexpression in diffuse large B-cell lymphoma
Resistance mechanisms of non-Hodgkin lymphomas against rituximab treatment
Deletion of chromosome bands 11q22-q23 in lymphoproliferative disorders and the genetics of mantle cell lymphoma
Prognostic molecular factors and algorithms in diffuse large b-cell lymphoma
Circadian rhythm disruptions and health
Non-responsive coeliac disease
Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) in hematological malignancies
Plerixafor in autologous stem cell transplantation
